Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...

Angelica Leicht is a seasoned personal finance writer and editor with nearly two decades of experience but just one goal: to help readers make the best decisions for their wallets. Her expertise spans ...